salvigenin
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2012 (NCT01898923)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 5-hydroxy-6,7,4'-trimethoxyflavone
- 5-hydroxy-6,7,4'-trimethoxy-flavone
- 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)- 4h-1-benzopyran-4-one
- salvigenin
- salvigenin
- salvigenin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02353273 | Phase 1 | Jul 1, 2015 | Government of Taiwan, Microbio Co Ltd |
| NCT01898923 | Phase 3 | Sep 1, 2012 | Chang Gung University, Microbio Co Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Microbio Co Ltd | For profit | 2 | 2 | 2 | 2012 |
| Chang Gung University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Government of Taiwan | Government | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1